spacer image
Untitled Document

About ComACC

Bylaws

Commissioners

Links

Standards and Guidelines

Self-Study Guidelines

Training Programs

ComACC Home

 


COMACC HOME > Training Programs > The University of Texas Southwestern Medical Center at Dallas

The University of Texas Southwestern Medical Center at Dallas

Director: Address:

Frank H. Wians, Jr., Ph.D., DABCC, FACB
Telephone: 214-648-7634/2038
Fax: 214-648-8037
E-mail: Frank.Wians@UTSouthwestern.edu

Department of Pathology
UT Southwestern Medical Center
5323 Harry Hines Boulevard
Dallas, TX 75390-9073

Faculty and Research Interests

University of Washington Medical Center

Ibrahim I. Hashim, PhD, DABCC, FACB

Clinical chemistry; immunochemistry

Susan Hilton, MD, FACP

Clinical chemistry; anatomic pathology

Patricia M. Jones, PhD, DABCC, FACB

Pediatric clinical chemistry

Martin H. Kroll, MD, FACP, FACB Clinical chemistry; anatomic pathology

Paul J. Orsulak, PhD, FACB

Toxicology; trace metal analysis; therapeutic drug monitoring

Elizabeth L. Todd, PhD

Forensic pathology

Frank H. Wians, Jr., PhD, DABCC, FACB Clinical chemistry; tumor markers

Jiaxi Wu, PhD, MD, DABCC

Clinical chemistry; molecular pathology

Program Listing:

Level(s) of training:
Number of positions available per year:
Duration of program:
Approximate annual salary or stipend:
Source of funding:
Current number of trainees:
Number of past graduates:
Date of ComACC accreditation:

Post-doctoral
1
1 year with option for additional year
$40,072
Departmental/Research Grant
2
1
1 Dec 04

Application Procedures:

Prerequisites: PhD in biological sciences or MD; adequate education in biological chemistry at the graduate level. MD candidate must obtain a Texas Institutional Permit.

Procedures:

Follow instructions and complete application at website: http://pathcuric1.swmed.edu/Teaching/fellowship/clinical_fellow.htm
Only applicants who complete the on-line application process, including sub-mission of all necessary supporting documents, will be competitively considered for selection (i.e., do NOT send C.V. only directly to Program Director). On-site interview, at candidate’s expense, required.

Deadline: 31 December of the year preceding the 1 Jul start date of the CCF Program


Program Description

The University of Texas Southwestern Medical Center (UTSWMC) at Dallas consists of 3 large or medium-size full service hospitals, a children’s hospital, an ambulatory care facility, and a veteran’s hospital: Parkland Health & Hospital Systems, St. Paul and Zale Lipshy University Hospitals, Aston Ambulatory Care Center, Children’s Medical Center, and the Veteran’s Administration Medical Center.

The Clinical Chemistry Fellowship (CCF) Program at UTSWMC provides trainees with the basic skills required for the practice of clinical chemistry in an academic or community hospital or indus-trial setting and to successfully complete the board examination in clinical chemistry administered by the American Board of Clinical Chemistry (ABCC) or the American College of Pathology (ACP). Mechanisms for achieving these goals include: mentoring by members of the clinical chemistry faculty; participation in a research project under the direction of his/her Clinical Chemis-try Research and Faculty Advisor; coordinating with a faculty member and overseeing pathology residents providing direct assistance to Interventional Radiologists in the surgical suite on patients undergoing bilateral inferior petrosal sinus sampling (IPSS), adrenal vein sampling (AVS), or selec-tive sampling for parathormone (PTH); participation in, at the discretion of the trainee’s Research and Faculty Advisor on an as needed basis, other special projects/tasks, not defined herein, with di-rect teaching value and benefit to the trainee.

In addition, attendance by the CCF is required at a variety of symposia with extensive learning benefit and value, including weekly Internal Medicine Grand Rounds, a forum for members of the Department of Internal Medicine at UTSWMC to present a mini-review of a clinical medicine topic related to their area of expertise and specialization; monthly Clinical Chemistry Grand Rounds Lec-ture Series, a forum for presentations by well known outside speakers on topics directly related to clinical chemistry; annual Laboratory Management Course for Pathology Residents; annual review of the Pathology Resident In-Service Examination (RISE); annual Progress in Clinical Pathology Course; and, funding permitting, the annual meeting of the American Association for Clinical Chemistry (AACC) and at local meetings of other professional and scientific organizations [e.g., Texas Section, AACC, Clinical Ligand Assay Society (CLAS)].

Prior to completion of the Fellowship program, the Fellow will be required to attain a satisfactory score on a Comprehensive Examination.

Upon completion of the CCF, fellows should be familiar with the principal indication for clinician ordering, the principle, and interpretation of a wide variety of clinical chemistry tests and proce-dures; be able to assist clinicians in the appropriate use and interpretation of clinical laboratory tests for a wide variety of diseases; know the rationale, procedure, and interpretation of results for the inferior petrosal sinus sampling, adrenal vein sampling, and selective sampling for PTH procedures; be familiar with the requirements of the Clinical Laboratory Improvement Amendments of 1988 (CLIA ’88) as they pertain to clinical chemistry laboratories; know the principles and methods used for evaluating and validating the analytical and clinical performance characteristics of clinical chemistry tests, including basic statistical techniques; be familiar with modern concepts of effective management, administrative, and leadership strategies; and, understand the principles and methods for establishing a clinical chemistry quality control/quality assurance (QC/QA) program.